Depression in Alzheimer's Disease (DIADS-2)

Trial Profile

Depression in Alzheimer's Disease (DIADS-2)

Completed
Phase of Trial: Phase II/III

Latest Information Update: 13 Apr 2017

At a glance

  • Drugs Sertraline (Primary)
  • Indications Alzheimer's disease; Depressive disorders
  • Focus Therapeutic Use
  • Acronyms DIADS-2
  • Most Recent Events

    • 01 Jun 2011 Results published in the International Journal of Geriatric Psychiatry.
    • 01 Feb 2010 Status changed from recruiting to active, no longer recruiting.
    • 01 Feb 2010 Results published in the American Journal of Geriatric Psychiatry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top